Sedana Medical reports NICE recommendation for Sedaconda ACD.

NORDIC BUSINESS REPORT-January 27, 2022-Sedana Medical reports NICE recommendation for Sedaconda ACD

(C)2022 M2 COMMUNICATIONS http://www.m2.com

Swedish medtech and pharmaceutical company Sedana Medical AB (Nasdaq First North Growth Market:SEDANA) revealed on Thursday that Sedaconda ACD has been recommended by the UK's National Institute for Health and Care Excellence (NICE).

NICE has issued positive guidance recommending Sedaconda ACD as a cost-saving option for delivering inhaled sedation in intensive care in England and Wales as an alternative to intravenous sedation.

According to Sedana Medical, cost modelling shows cost savings compared with intravenous sedation of almost GBP4,000 per adult patient (30-day time horizon for adult...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT